Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, April 06, 2010

press release: Driven by the Approval and Rapid Uptake of Avastin, the Ovarian Cancer Drug Market Will More Than Triple to Nearly $1.5 Billion in 2018

avastin

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.